QR Code

The role of Atogepant in migraine prevention: a systematic review and meta-analysis

Abstract Background Atogepant is a CGRP receptor antagonist used in prevention of migraine. This study assesses the safety and efficacy of this drug in management of migraine headaches. Methods PubMed, Scopus, Web of Science, and Cochrane CENTRAL were searched until March 24, 2025. Outcomes assessed...

Description complète

Enregistré dans:
Auteurs principaux: Naresh Kumar Ladhwani, Priya Bai, Rohan Lal, Aresha Masood Shah, Sheela Bai, Ghazi Uddin Ahmed, Rimsha Zameer, Varisha Fatima Shaikh, Arsalan Hyder, Sikander Ali, Muhammad Hamza Beg, Maheen Adeeb, Mahir Tesfaye
Format: Artigo
Langue:Inglês
Publié: BMC 2025-09-01
Collection:BMC Neurology
Sujets:
Atogepant
CGRP antagonist
Chronic migraine
Episodic migraine
Meta-analysis
Accès en ligne:https://doi.org/10.1186/s12883-025-04394-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires